School of Medicine


Showing 701-710 of 729 Results

  • Phillip C. Yang, MD

    Phillip C. Yang, MD

    Professor of Medicine (Cardiovascular Medicine)

    Current Research and Scholarly InterestsDr. Yang is a physician-scientist whose research interest focuses on clinical translation of the fundamental molecular and cellular processes of myocardial restoration. His research employs novel in vivo multi-modality molecular and cellular imaging technology to translate the basic innovation in cardiovascular pluripotent stem cell biologics. Dr. Yang is currently a PI on the NIH/NHLBI funded CCTRN UM1 grant, which is designed to conduct multi-center clinical trial on novel biological therapy.

  • Yunzhi Peter Yang

    Yunzhi Peter Yang

    Professor of Orthopaedic Surgery and, by courtesy, of Materials Science and Engineering and of Bioengineering

    Current Research and Scholarly InterestsYang’ lab's research interests are in the areas of bio-inspired biomaterials, medical devices, and 3D printing approaches for re-creating a suitable microenvironment for cell growth and tissue regeneration for musculoskeletal disease diagnosis and treatment, including multiple tissue healing such as rotator cuff injury, orthopedic diseases such as osteoporosis and osteonecrosis, and orthopedic traumas such as massive bone and muscle injuries.

  • Alan Yeung, MD

    Alan Yeung, MD

    Li Ka Shing Professor in Cardiology

    Current Research and Scholarly InterestsCoronary artery disease is the leading cause of death in men and women in the United States. Our group is interested in studying both the early and late phases of atherosclerosis so that we can better develop prevention and treatment strategies.

  • Paul Yock, MD

    Paul Yock, MD

    Emeritus Faculty, Acad Council, Miscellaneous

    BioYock began his faculty career as an interventional cardiologist at UC San Francisco and then moved to Stanford in 1994. Yock is known for his work in inventing, developing and testing new devices, including the Rapid Exchange angioplasty and stenting system, which is the primary approach used worldwide. Yock also authored the fundamental patents for intravascular ultrasound imaging, conducted the initial clinical trials and established the Stanford Center for Research in Cardiovascular Interventions as a core laboratory for analysis of intravascular ultrasound clinical studies. He also invented the Smart Needle and is a co-inventor of the strain-reduction patch for wound healing. Yock was founding Co-Chair of the Department of Bioengineering and continues research related to new device technologies. Yock also was the founding director of the Stanford Byers Center for Biodesign -dedicated to advanced training in medical technology innovation.

  • Celina Yong, MD, MBA, MSc

    Celina Yong, MD, MBA, MSc

    Associate Professor of Medicine (Cardiovascular Medicine)

    BioCelina Yong, MD, MBA, MSc is Director of Interventional Cardiology at the Palo Alto VA Medical Center and an Associate Professor in the Division of Cardiovascular Medicine at Stanford. Dr. Yong completed her medical training at Stanford School of Medicine and her internal medicine residency at the University of California, San Francisco. She completed her cardiology and interventional cardiology fellowships at Stanford, including serving as Chief Fellow. As a Marshall Scholar, she completed a Masters in Health Policy, Planning and Financing from the London School of Economics and an MBA from Oxford.

    Dr. Yong’s current research focuses on understanding and reducing inequities in cardiovascular care for patients, as well as resolving gender imbalances in the medical profession itself. She is actively involved in clinical trials of novel devices for percutaneous coronary and structural intervention, and performs structural and coronary interventions at the Palo Alto VA Hospital.

  • Roham Zamanian

    Roham Zamanian

    Professor of Medicine (Pulmonary and Critical Care Medicine)

    Current Research and Scholarly Interests1. Development and evaluation of prognostic and diagnostic integral biomarkers in PAH.

    2. Prevalence and Treatment of Insulin Resistance in PAH.

    3. Role of inflammation and proteomic signature in PAH

    4. Development of novel therapeutics (bench to bedside) including FK506 & Elastase Inhibition in PAH.

    5. Assessment of Vasoreactivity (gain and loss) in pulmonary arterial hypertension

    6. Assessment of microvascular function in PAH.